Nicholas Pesa, MD
Specialty: Anesthesiology-Critical Care
- Associate Program Director, Anesthesiology, UH Cleveland Medical Center
- Chief Quality Officer, Critical Care Medicine, Department of Anesthesiology and Perioperative Medicine, UH Cleveland Medical Center
- Chief, Surgical Critical Care, UH Cleveland Medical Center
- Clinical Assistant Professor, CWRU School of Medicine
- Division Chief, Transplant Anesthesia, UH Cleveland Medical Center
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland, OH 44106
Nick Pesa, MD, is a critical care anesthesiologist and associate program director for anesthesiology at University Hospitals. He is also division chief of transplant anesthesia and chief quality officer of critical care medicine in the Department of Anesthesiology. Dr. Pesa is an assistant professor of anesthesiology at Case Western Reserve University School of Medicine and is board certified in both anesthesiology and critical care medicine.
Dr. Pesa is a native of Cleveland. He earned both his undergraduate degree and his medical degree at Case Western Reserve University in Cleveland. He completed residency training in anesthesiology and a critical care fellowship at University Hospitals in Cleveland.
- Critical Care Anesthesiology
- Liver Transplant Anesthesia
- Critical Care Medicine - American Board of Anesthesiology
- Anesthesiology - American Board of Anesthesiology
Fellowship | Critical Care Anesthesiology
Critical Care Anesthesiology - Uh Case Medical Center (2012 - 2013)
Residency | Anesthesiology
Anesthesiology - Uh Case Medical Center (2009 - 2012)
Internship | Rotator
Rotator - Uh Case Medical Center (2008 - 2009)
Case Western Reserve University School Of Medicine (2008)
Case Western Reserve University (2003)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Nicholas Pesa did not disclose any Outside Relationships with Industry.